Literature DB >> 29056286

Methotrexate-associated osteonecrosis of the jaw: A report of two cases.

Marianne Henien1, Barbara Carey2, Esther Hullah2, Chris Sproat1, Vinod Patel3.   

Abstract

There has been a rise in medication-related osteonecrosis of the jaw (MRONJ) predominantly related to antiresorptive and antiangiogenic medications. More evidence is revealing that MRONJ is not limited to these drug groups. With the introduction of newer and varied medications used in the treatment of cancer and autoimmune diseases, reports of possible related osteonecrosis of the jaw (ONJ) are also on the rise. We present 2 cases of ONJ in patients with long-standing arthritis treated with methotrexate in the absence of a lymphoproliferative disorder and antiresorptive or antiangiogenic medications.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29056286     DOI： 10.1016/j.oooo.2017.09.005

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  8 in total

1.  Pharmacology: MRONJ risk factor.

Authors:  D Patel; V Patel
Journal:  Br Dent J       Date:  2018-02-23       Impact factor: 1.626

2.  Low-dose methotrexate in rheumatoid arthritis: a potential risk factor for bisphosphonate-induced osteonecrosis of the jaw.

Authors:  Paul C Mathai; Neelam N Andrade; Neha Aggarwal; Shibani Nerurkar; Prathmesh Kapoor
Journal:  Oral Maxillofac Surg       Date:  2018-03-05

Review 3.  Novel insight into the management of bisphosphonate-related osteonecrosis of the jaw (BRONJ).

Authors:  Hiromitsu Kishimoto; Kazuma Noguchi; Kazuki Takaoka
Journal:  Jpn Dent Sci Rev       Date:  2019-05-17

4.  A Retrospective Data Analysis for the Risk Evaluation of the Development of Drug-Associated Jaw Necrosis through Dentoalveolar Interventions.

Authors:  Mayte Buchbender; Charlotte Bauerschmitz; Sebastian Pirkl; Marco R Kesting; Christian M Schmitt
Journal:  Int J Environ Res Public Health       Date:  2022-04-04       Impact factor: 3.390

Review 5.  The impact of sex steroids on osteonecrosis of the jaw.

Authors:  Ranhee Kim; Sung Woo Kim; Hoon Kim; Seung-Yup Ku
Journal:  Osteoporos Sarcopenia       Date:  2022-06-17

Review 6.  Recent perspectives on the association between osteonecrosis and bone mineral density decline in childhood acute lymphoblastic leukemia.

Authors:  Jenneke E van Atteveld; Demi Tc de Winter; Rob Pieters; Sebastian Jcmm Neggers; Marry M van den Heuvel-Eibrink
Journal:  Fac Rev       Date:  2021-06-23

Review 7.  Review and update on drugs related to the development of osteonecrosis of the jaw.

Authors:  A Eguia; L Bagán-Debón; F Cardona
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2020-01-01

Review 8.  Osteonecrosis of the Jaws in Patients with Hereditary Thrombophilia/Hypofibrinolysis-From Pathophysiology to Therapeutic Implications.

Authors:  Minerva Codruta Badescu; Elena Rezus; Manuela Ciocoiu; Oana Viola Badulescu; Lacramioara Ionela Butnariu; Diana Popescu; Ioana Bratoiu; Ciprian Rezus
Journal:  Int J Mol Sci       Date:  2022-01-07       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.